Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction

Roberts, KA, Colley, L, Agbaedeng, TA, Ellison-Hughes, GM and Ross, MD (2020) Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction. Frontiers in Cardiovascular Medicine, 7. ISSN 2297-055X

[img]
Preview
Text
Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
Open Access URL: https://www.frontiersin.org/articles/10.3389/fcvm.... (Published version)

Abstract

The coronavirus pandemic has reportedly infected over 31.5 million individuals and caused over 970,000 deaths worldwide (as of 22nd Sept 2020). This novel coronavirus, officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), although primarily causes significant respiratory distress, can have significant deleterious effects on the cardiovascular system. Severe cases of the virus frequently result in respiratory distress requiring mechanical ventilation, often seen, but not confined to, individuals with pre-existing hypertension and cardiovascular disease, potentially due to the fact that the virus can enter the circulation via the lung alveoli. Here the virus can directly infect vascular tissues, via TMPRSS2 spike glycoprotein priming, thereby facilitating ACE-2-mediated viral entry. Clinical manifestations, such as vasculitis, have been detected in a number of vascular beds (e.g., lungs, heart, and kidneys), with thromboembolism being observed in patients suffering from severe coronavirus disease (COVID-19), suggesting the virus perturbs the vasculature, leading to vascular dysfunction. Activation of endothelial cells via the immune-mediated inflammatory response and viral infection of either endothelial cells or cells involved in endothelial homeostasis, are some of the multifaceted mechanisms potentially involved in the pathogenesis of vascular dysfunction within COVID-19 patients. In this review, we examine the evidence of vascular manifestations of SARS-CoV-2, the potential mechanism(s) of entry into vascular tissue and the contribution of endothelial cell dysfunction and cellular crosstalk in this vascular tropism of SARS-CoV-2. Moreover, we discuss the current evidence on hypercoagulability and how it relates to increased microvascular thromboembolic complications in COVID-19.

Item Type: Article
Uncontrolled Keywords: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; COVID-19; endothelium; pericyte; coronavirus; thromboembolism; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; SARS CORONAVIRUS; CYTOKINE STORM; INFECTION; PROTEIN; SYSTEM; ACE2; MICROPARTICLES; COMPLICATIONS
Subjects: R Medicine > RC Internal medicine > RC1200 Sports Medicine
Divisions: Sport & Exercise Sciences
Publisher: Frontiers Media
Related URLs:
Date Deposited: 02 Dec 2020 11:30
Last Modified: 02 Dec 2020 11:30
DOI or Identification number: 10.3389/fcvm.2020.598400
URI: https://researchonline.ljmu.ac.uk/id/eprint/14118

Actions (login required)

View Item View Item